Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$363K Buy
+5,611
New +$396K 0.01% 2316
2025
Q4
Sell
-21,340
Closed -$1.57M 3493
2025
Q3
$1.57M Sell
21,340
-8,568
-29% -$569K 0.08% 311
2025
Q2
$1.56M Buy
29,908
+11,538
+63% +$657K 0.06% 436
2025
Q1
$1.17M Buy
18,370
+3,911
+27% +$227K 0.06% 473
2024
Q4
$691K Buy
+14,459
New +$741K 0.06% 510
2023
Q4
Sell
-28,504
Closed -$1.09M 1788
2023
Q3
$1.09M Buy
28,504
+21,950
+335% +$899K 0.19% 82
2023
Q2
$236K Buy
+6,554
New +$224K 0.04% 894
2021
Q2
Sell
-13,874
Closed -$578K 920
2021
Q1
$578K Buy
+13,874
New +$633K 0.28% 61

Other funds holding HALO

XTX Topco's HALO Position: Q1 2026 in Review

XTX Topco opened a new position in Halozyme (HALO) in Q1 2026: 5,611 shares worth $363K. The stake represents 0.01% of the portfolio and ranks #2316 among its holdings. This is a return to the name: XTX Topco previously reported a position in HALO as recently as Q3 2025.

XTX Topco first reported a position in HALO in Q1 2021 and has held it in 8 quarters since. The position peaked at $1.57M in Q3 2025. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • XTX Topco held 5,611 shares of Halozyme worth $363K as of Q1 2026.
  • Halozyme was a new XTX Topco position in Q1 2026.
  • Halozyme made up 0.01% of XTX Topco's portfolio in Q1 2026, its #2316 holding.
  • XTX Topco first reported a position in Halozyme in Q1 2021 and has held it in 8 quarters since.
  • XTX Topco's Halozyme position peaked at $1.57M in Q3 2025.
  • 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.